相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Site-specific covalent labeling of His-tag fused proteins with N-acyl-N-alkyl sulfonamide reagent
Vikram Thimaradka et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Development of a Cell-Based Ligand-Screening System for Identifying Hsp90 Inhibitors
Tsuyoshi Ueda et al.
BIOCHEMISTRY (2020)
Global targeting of functional tyrosines using sulfur-triazole exchange chemistry
Heung Sik Hahm et al.
NATURE CHEMICAL BIOLOGY (2020)
Ligand Conformational Bias Drives Enantioselective Modification of a Surface-Exposed Lysine on Hsp90
Adolfo Cuesta et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemia
Pau Montesinos et al.
FUTURE ONCOLOGY (2020)
Bicyclobutane Carboxylic Amide as a Cysteine-Directed Strained Electrophile for Selective Targeting of Proteins
Keisuke Tokunaga et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues
Luca Gambini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
Matthias Gehringer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Chemistry for Covalent Modification of Endogenous/Native Proteins: From Test Tubes to Complex Biological Systems
Tomonori Tamura et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Selective and reversible modification of kinase cysteines with chlorofluoroacetamides
Naoya Shindo et al.
NATURE CHEMICAL BIOLOGY (2019)
Targeted covalent inhibitors of MDM2 using electrophile-bearing stapled peptides
Jiraborrirak Charoenpattarapreeda et al.
CHEMICAL COMMUNICATIONS (2019)
Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation
Tinghu Zhang et al.
CELL CHEMICAL BIOLOGY (2019)
Inverse Drug Discovery Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
David E. Mortenson et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Structure-based design of targeted covalent inhibitors
Richard Lonsdale et al.
CHEMICAL SOCIETY REVIEWS (2018)
Rapid labelling and covalent inhibition of intracellular native proteins using ligand-directed N-acyl-N-alkyl sulfonamide
Tomonori Tamura et al.
NATURE COMMUNICATIONS (2018)
jPOSTrepo: an international standard data repository for proteomes
Shujiro Okuda et al.
NUCLEIC ACIDS RESEARCH (2017)
Targeting the N terminus for site-selective protein modification
Christian B. Rosen et al.
NATURE CHEMICAL BIOLOGY (2017)
Targeted Covalent Inhibitors for Drug Design
Thomas A. Baillie
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Proximity-enabled bioreactivity to generate covalent peptide inhibitors of p53-Mdm4
Christian Hoppmann et al.
CHEMICAL COMMUNICATIONS (2016)
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
Wentao Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
Kenneth S. Thress et al.
NATURE MEDICINE (2015)
Synthesis of gamma-labeled nucleoside 5 '-triphosphates using click chemistry
S. Serdjukow et al.
CHEMICAL COMMUNICATIONS (2014)
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Michelle R. Arkin et al.
CHEMISTRY & BIOLOGY (2014)
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
Bryan R. Lannine et al.
NATURE CHEMICAL BIOLOGY (2014)
Drugging the p53 pathway: understanding the route to clinical efficacy
Khoo Kian Hoe et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models
Christian Tovar et al.
CANCER RESEARCH (2013)
Discovery of RG7388, a Potent and Selective p53-MDM2 Inhibitor in Clinical Development
Qingjie Ding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Differential regulation of p21waf1 protein half-life by DNA damage and Nutlin-3 in p53 wild-type tumors and its therapeutic implications
Li-Ju Chang et al.
CANCER BIOLOGY & THERAPY (2012)
Ordering of the N-Terminus of Human MDM2 by Small Molecule Inhibitors
Klaus Michelsen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Protein-protein docking benchmark version 4.0
Howook Hwang et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Oligobenzamide proteomimetic inhibitors of the p53-hDM2 protein-protein interaction
Jeffrey P. Plante et al.
CHEMICAL COMMUNICATIONS (2009)
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
Marzena Pazgiera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Inhibiting the p53-MDM2 interaction:: An important target for cancer therapy
P Chène
NATURE REVIEWS CANCER (2003)
Covalent modification as a strategy to block protein-protein interactions with small-molecule drugs
JC Way
CURRENT OPINION IN CHEMICAL BIOLOGY (2000)
分享论文
